Expression of the Rat CD26 Antigen (dipeptidyl Peptidase IV) on Subpopulations of Rat Lymphocytes
Overview
Cell Biology
Authors
Affiliations
The T cell activation antigen CD26 has been recently identified as the cell surface ectopeptidase dipeptidyl peptidase IV (DPP-IV). DPP-IV is found on many cell types, including lymphocytes, epithelial cells, and certain endothelial cells. The MRC OX61 monoclonal antibody (MAb) which specifically recognises rat DPP-IV was used to examine the expression of CD26/DPP-IV on rat lymphocytes. The molecular nature of the antigen was examined by immunoprecipitation from thymocytes, splenocytes, and hepatocytes. Analysis by one- and two-dimensional gel electrophoresis indicated that the native form of CD26 includes a 220-kDa homodimer. On tissue sections MRC OX61 MAb stained nearly all thymocytes and in the spleen and lymph nodes predominantly stained the T cell areas. However, in immunofluorescence experiments OX61 stained 80 to 87% of lymph node cells and 78 to 85% of spleen cells. Furthermore, two-colour immunofluorescence analysis of the CD4+, CD8+, and Ig+ lymphocyte subsets indicated that only 2 to 5% of each of these subsets lacked OX61 staining. Spleen cells and thymocytes of both CD4+ and CD8+ subsets stained much more intensely with OX61 after these cells were stimulated with phytohemagglutinin. These findings indicate that rat CD26 antigen expression is not confined to the T cell population as has been suggested, but also occurs on B cells, and is increased on T cells following their activation.
Gaggini M, Sabatino L, Suman A, Chatzianagnostou K, Vassalle C Cells. 2025; 14(5).
PMID: 40072115 PMC: 11898734. DOI: 10.3390/cells14050387.
Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review of Structure-Activity Relationship Studies.
Bayanati M, Ismail Mahboubi Rabbani M, Sirous Kabiri S, Mir B, Rezaee E, Tabatabai S Iran J Pharm Res. 2025; 23(1):e151581.
PMID: 40066124 PMC: 11892788. DOI: 10.5812/ijpr-151581.
Host polymorphisms and COVID-19 infection.
Delanghe J, Speeckaert M Adv Clin Chem. 2022; 107:41-77.
PMID: 35337605 PMC: 8381193. DOI: 10.1016/bs.acc.2021.07.002.
Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease.
Huang J, Liu X, Wei Y, Li X, Gao S, Dong L Front Immunol. 2022; 13:830863.
PMID: 35309368 PMC: 8931313. DOI: 10.3389/fimmu.2022.830863.
Ahlstrom F, Matlik K, Viisanen H, Blomqvist K, Liu X, Lilius T Mol Neurobiol. 2021; 58(10):5396-5419.
PMID: 34331199 PMC: 8497331. DOI: 10.1007/s12035-021-02447-1.